' 
![]()
SCIENTIFIC SCORE
Moderately Effective
Based on 13 Researches
8.3
USERS' SCORE
Good
Based on 1 Review
8.5
Supplement Facts
Serving Size: 1 Capsule
Amount Per Serving
%DV
Proprietary Probiotic BlendSaccharomyces boulardiiLactobacillus plantarum LP01, Bifidobacterium breve BR03Total Cultures
300 mg5 Billion CFU5 Billion CFU 10 Billion CFU
*
Digestive Support Blend (from ferment media)Organic Aloe (leaf), Organic Peppermint (leaf), Organic Coriander (seed), Organic Cardamom (fruit), Organic Artichoke (leaf)
82.5 mg
*
Organic Turmeric (Curcuma longa) (rhizome) (from ferment media)
31.4 mg
*
Top Medical Research Studies
9
Saccharomyces boulardii shows ulcer benefits
Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Regulating NF-B and Nrf2 Signaling Pathways.
Identified effective ulcer treatment
We explored how the probiotic yeast, Saccharomyces boulardii, impacts ulcerative colitis in mice. Through a careful setup, C57BL/6 mice received the treatment for three weeks and were later exposed to a harmful substance to induce the condition.
The results were promising; we observed that Saccharomyces boulardii significantly improved various symptoms. It helped prevent weight loss, diarrhea, and inflammation while strengthening the intestinal barrier. Furthermore, it demonstrated an ability to counteract oxidative damage effectively.
However, we also noted that while these findings are positive, further research is needed to fully understand the comprehensive benefits of this treatment in humans.
The results were promising; we observed that Saccharomyces boulardii significantly improved various symptoms. It helped prevent weight loss, diarrhea, and inflammation while strengthening the intestinal barrier. Furthermore, it demonstrated an ability to counteract oxidative damage effectively.
However, we also noted that while these findings are positive, further research is needed to fully understand the comprehensive benefits of this treatment in humans.
Read More
9
Saccharomyces boulardii reduces ulcer risk
Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota.
Highly relevant therapeutic findings
We explored the effects of Saccharomyces boulardii on ulcerative colitis-related cancer in a mouse model.
Mice treated with a combination of azoxymethane and dextran sulfate sodium were given S. boulardii for 12 weeks.
Results showed that S. boulardii significantly lowered tumor load and reduced harmful substances TNF-α and IL-6 in the colon.
Additionally, it positively shifted the gut microbiota composition, suggesting a connection between the treatment and these beneficial outcomes.
Mice treated with a combination of azoxymethane and dextran sulfate sodium were given S. boulardii for 12 weeks.
Results showed that S. boulardii significantly lowered tumor load and reduced harmful substances TNF-α and IL-6 in the colon.
Additionally, it positively shifted the gut microbiota composition, suggesting a connection between the treatment and these beneficial outcomes.
Read More
9
Saccharomyces boulardii shows protective effects
Protective effects of Saccharomyces boulardii CNCM I-745 in an experimental model of NSAID-induced enteropathy.
High relevance for gastrointestinal health
We explored the effects of Saccharomyces boulardii (Sb) in mice with NSAID-induced enteropathy. Through various assessments, including clinical scores and intestinal analyses, we compared four groups: Control, Indomethacin, Sb, and Sb with Indomethacin.
Mice treated with Sb demonstrated significant improvements in their health compared to those only on indomethacin. Sb not only enhanced the intestinal barrier but also positively influenced gut bacteria, reducing inflammation and damage caused by NSAIDs.
Our findings suggest that Sb could serve as a protective agent against NSAID-related intestinal issues.
Mice treated with Sb demonstrated significant improvements in their health compared to those only on indomethacin. Sb not only enhanced the intestinal barrier but also positively influenced gut bacteria, reducing inflammation and damage caused by NSAIDs.
Our findings suggest that Sb could serve as a protective agent against NSAID-related intestinal issues.
Read More
Most Useful Reviews
9
Helpful probiotic solution
I appreciate the inclusion of Cardamom and Saccharomyces boulardii in this probiotic. It has a unique blend designed to support digestion, which seems beneficial for a family member struggling with ulcerative colitis. It has proved useful without any harm, so we plan to continue using it.
Read More
Most Recommended Products for Ulcer
Medical Researches
SCIENTIFIC SCORE
Moderately Effective
Based on 13 Researches
8.3
9.5
Probiotic reduces side effects
Effectiveness of 7-Day and 14-Day Moxifloxacin-Dexlansoprazole Based Triple Therapy and Probiotic Supplement for Helicobacter Pylori Eradication in Thai Patients with Non-Ulcer Dyspepsia: A Double-Blind Randomized Placebo-Controlled Study.
Highly relevant probiotic findings
We looked into how the probiotic Saccharomyces boulardii affects the treatment of Helicobacter pylori in Thai patients. In a double-blind study, participants received either a probiotic or placebo with a moxifloxacin-dexlansoprazole therapy.
While the treatment achieved high eradication rates of H. pylori, we found that the addition of the probiotic significantly reduced side effects like nausea and diarrhea compared to those on placebo. This suggests that Saccharomyces boulardii could enhance patient comfort during an effective antibiotic regimen.
While the treatment achieved high eradication rates of H. pylori, we found that the addition of the probiotic significantly reduced side effects like nausea and diarrhea compared to those on placebo. This suggests that Saccharomyces boulardii could enhance patient comfort during an effective antibiotic regimen.
Read More
9
Saccharomyces boulardii aids ulcer treatment
Alleviates Colitis by Regulating FXR-NLRP3 Mediated Macrophage Pyroptosis.
High relevance for colitis management
This study examined how Saccharomyces boulardii supernatant (SbS) impacts ulcerative colitis (UC) by activating the FXR-NLRP3 signaling pathway. We used a murine model to assess the effects of SbS compared to a control group.
Our findings showed that SbS not only activated FXR but also suppressed the NLRP3 inflammasome in colonic tissues. It reduced macrophage pyroptosis, a process linked to inflammation. However, the benefits were reversed by an FXR inhibitor, indicating that FXR’s activation is crucial for SbS's effects.
Our findings showed that SbS not only activated FXR but also suppressed the NLRP3 inflammasome in colonic tissues. It reduced macrophage pyroptosis, a process linked to inflammation. However, the benefits were reversed by an FXR inhibitor, indicating that FXR’s activation is crucial for SbS's effects.
Read More
9
Targeted Saccharomyces boulardii benefits ulcerative colitis
Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis.
Innovative treatment for bowel diseases
We investigated the impact of a targeted delivery system for Saccharomyces boulardii, a probiotic yeast, aimed at treating ulcerative colitis. In our preclinical studies on female mice, we found that this engineered strain significantly improved gut retention time, increasing it by an extra 24-48 hours.
This enhanced delivery led to a dramatic boost in the concentration of the probiotic in the colon, which resulted in notable improvements in colon health markers. Key indicators like colon length and inflammation scores returned to healthier levels, suggesting promising potential for this targeted treatment strategy in managing inflammatory bowel diseases.
This enhanced delivery led to a dramatic boost in the concentration of the probiotic in the colon, which resulted in notable improvements in colon health markers. Key indicators like colon length and inflammation scores returned to healthier levels, suggesting promising potential for this targeted treatment strategy in managing inflammatory bowel diseases.
Read More
9
Saccharomyces boulardii shows protective effects
Protective effects of Saccharomyces boulardii CNCM I-745 in an experimental model of NSAID-induced enteropathy.
High relevance for gastrointestinal health
We explored the effects of Saccharomyces boulardii (Sb) in mice with NSAID-induced enteropathy. Through various assessments, including clinical scores and intestinal analyses, we compared four groups: Control, Indomethacin, Sb, and Sb with Indomethacin.
Mice treated with Sb demonstrated significant improvements in their health compared to those only on indomethacin. Sb not only enhanced the intestinal barrier but also positively influenced gut bacteria, reducing inflammation and damage caused by NSAIDs.
Our findings suggest that Sb could serve as a protective agent against NSAID-related intestinal issues.
Mice treated with Sb demonstrated significant improvements in their health compared to those only on indomethacin. Sb not only enhanced the intestinal barrier but also positively influenced gut bacteria, reducing inflammation and damage caused by NSAIDs.
Our findings suggest that Sb could serve as a protective agent against NSAID-related intestinal issues.
Read More
9
Saccharomyces boulardii shows ulcer benefits
Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Regulating NF-B and Nrf2 Signaling Pathways.
Identified effective ulcer treatment
We explored how the probiotic yeast, Saccharomyces boulardii, impacts ulcerative colitis in mice. Through a careful setup, C57BL/6 mice received the treatment for three weeks and were later exposed to a harmful substance to induce the condition.
The results were promising; we observed that Saccharomyces boulardii significantly improved various symptoms. It helped prevent weight loss, diarrhea, and inflammation while strengthening the intestinal barrier. Furthermore, it demonstrated an ability to counteract oxidative damage effectively.
However, we also noted that while these findings are positive, further research is needed to fully understand the comprehensive benefits of this treatment in humans.
The results were promising; we observed that Saccharomyces boulardii significantly improved various symptoms. It helped prevent weight loss, diarrhea, and inflammation while strengthening the intestinal barrier. Furthermore, it demonstrated an ability to counteract oxidative damage effectively.
However, we also noted that while these findings are positive, further research is needed to fully understand the comprehensive benefits of this treatment in humans.
Read More
User Reviews
USERS' SCORE
Good
Based on 1 Review
8.5
9
Helpful probiotic solution
I appreciate the inclusion of Cardamom and Saccharomyces boulardii in this probiotic. It has a unique blend designed to support digestion, which seems beneficial for a family member struggling with ulcerative colitis. It has proved useful without any harm, so we plan to continue using it.
Read More
